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The name 'hadrontherapy' is being
currently recommended by accelerator physicist,
although it has not, as yet, become widely known
in the medical world. It denotes the therapy of
radioresistant tumours or those located near
critical body structures, using elementary
particles as neutrons, protons, pions, helium ions
and/or heavy and light ions. The progress in the
construction and use of accelerators has made it
possible to use hadrontherapy on a larger scale.
Protons and light ions are suitable for conformal
treatments, and those with high LET values can
be used radioresistant tumours, whereas
neutrons, Especially in the so-called BNTC
(Boron-Neutron Capture Therapy) therapy are
proposed for deep, inoperable brain tumours.
Pions, i.e. negative n- mesons, produced in
meson 'factories' have the advantage of a high
dose within the tumour area and low dose in the
healthy tissues. Protons with low energies are
being used in irradiating eye tumours, and those
with high energies are suitable for large and
deep tumours. There are at present 16 proton
centres the world over; the project Progretto
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Adroterapia being implemented in Italy is of
special importance since it is planned to treat
about 12,000 patients annually. In the USA
(Lama Linda) a dedicated hospital proton
accelerator has been built and in Boston a
cyclotron was put into operation to employ
protons clinically. In Japan (Tsukuba), an
accelerator is also being constructed to use
protons for medical purposes. The use of light
ions of neon, carbon and oxygen have been
initiated at Berkeley (USA) for the treatment of
2000 patients with eye tumours. The HIMAC
programme in Japan is also· envisaged
exclusively for medical applications. The
European EULIMA programme came to an end in
1991, whereas at GSI the treatment with light
ions was started in the late 1996.
It may be concluded that what we are
witnessing now is a transformation period of
proton therapy into a fully routine method, while
the work on neutron therapy (particularly BNTC)
and the use of accelerators for the production of
light ions for medical purposes has every chance
of success in the not too distant future.
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